EDWARDS LIFESCIENCES CORP (EWL.DE) Stock Fundamental Analysis
FRA:EWL - Deutsche Boerse Ag - US28176E1082 - Common Stock - Currency: EUR
Overall EWL gets a fundamental rating of 7 out of 10. We evaluated EWL against 57 industry peers in the Health Care Equipment & Supplies industry. EWL gets an excellent profitability rating and is at the same time showing great financial health properties. EWL is quite expensive at the moment. It does show a decent growth rate. These ratings would make EWL suitable for quality investing!
1. Profitability
1.1 Basic Checks
In the past year EWL was profitable.
In the past year EWL had a positive cash flow from operations.
EWL had positive earnings in each of the past 5 years.
Each year in the past 5 years EWL had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of 32.10%, EWL belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
With an excellent Return On Equity value of 41.28%, EWL belongs to the best of the industry, outperforming 98.25% of the companies in the same industry.
With a decent Return On Invested Capital value of 9.29%, EWL is doing good in the industry, outperforming 75.44% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for EWL is above the industry average of 8.57%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 32.1% | ||
| ROE | 41.28% | ||
| ROIC | 9.29% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
1.3 Margins
With an excellent Profit Margin value of 75.48%, EWL belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
EWL's Profit Margin has improved in the last couple of years.
EWL has a better Operating Margin (27.71%) than 94.74% of its industry peers.
EWL's Operating Margin has been stable in the last couple of years.
Looking at the Gross Margin, with a value of 79.38%, EWL belongs to the top of the industry, outperforming 87.72% of the companies in the same industry.
In the last couple of years the Gross Margin of EWL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.71% | ||
| PM (TTM) | 75.48% | ||
| GM | 79.38% |
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), EWL is creating some value.
The number of shares outstanding for EWL has been reduced compared to 1 year ago.
EWL has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, EWL has an improved debt to assets ratio.
2.2 Solvency
EWL has an Altman-Z score of 12.15. This indicates that EWL is financially healthy and has little risk of bankruptcy at the moment.
EWL has a Altman-Z score of 12.15. This is amongst the best in the industry. EWL outperforms 96.49% of its industry peers.
The Debt to FCF ratio of EWL is 0.96, which is an excellent value as it means it would take EWL, only 0.96 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of EWL (0.96) is better than 91.23% of its industry peers.
EWL has a Debt/Equity ratio of 0.06. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.06, EWL belongs to the top of the industry, outperforming 89.47% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.96 | ||
| Altman-Z | 12.15 |
ROIC/WACC1.05
WACC8.81%
2.3 Liquidity
EWL has a Current Ratio of 4.45. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
EWL has a Current ratio of 4.45. This is amongst the best in the industry. EWL outperforms 91.23% of its industry peers.
EWL has a Quick Ratio of 3.66. This indicates that EWL is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.66, EWL belongs to the top of the industry, outperforming 91.23% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.45 | ||
| Quick Ratio | 3.66 |
3. Growth
3.1 Past
The earnings per share for EWL have decreased by -0.77% in the last year.
EWL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.13% yearly.
EWL shows a decrease in Revenue. In the last year, the revenue decreased by -1.09%.
EWL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.58% yearly.
EPS 1Y (TTM)-0.77%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%-4.29%
Revenue 1Y (TTM)-1.09%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%-6.13%
3.2 Future
The Earnings Per Share is expected to grow by 9.07% on average over the next years. This is quite good.
Based on estimates for the next years, EWL will show a quite strong growth in Revenue. The Revenue will grow by 8.27% on average per year.
EPS Next Y-2.43%
EPS Next 2Y4.32%
EPS Next 3Y6.72%
EPS Next 5Y9.07%
Revenue Next Year3.42%
Revenue Next 2Y6.49%
Revenue Next 3Y7.7%
Revenue Next 5Y8.27%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 30.13, which means the current valuation is very expensive for EWL.
Based on the Price/Earnings ratio, EWL is valued a bit cheaper than the industry average as 68.42% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.41, EWL is valued at the same level.
EWL is valuated quite expensively with a Price/Forward Earnings ratio of 27.20.
The rest of the industry has a similar Price/Forward Earnings ratio as EWL.
When comparing the Price/Forward Earnings ratio of EWL to the average of the S&P500 Index (33.87), we can say EWL is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.13 | ||
| Fwd PE | 27.2 |
4.2 Price Multiples
EWL's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of EWL is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 73.01 | ||
| EV/EBITDA | 24.55 |
4.3 Compensation for Growth
The excellent profitability rating of EWL may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)4.23
EPS Next 2Y4.32%
EPS Next 3Y6.72%
5. Dividend
5.1 Amount
No dividends for EWL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:EWL (8/8/2025, 7:00:00 PM)
66.58
-0.14 (-0.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.93%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap39.06B
Analysts76.28
Price Target76.39 (14.73%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.76%
Min EPS beat(2)3.4%
Max EPS beat(2)4.11%
EPS beat(4)3
Avg EPS beat(4)1.75%
Min EPS beat(4)-2.08%
Max EPS beat(4)4.11%
EPS beat(8)3
Avg EPS beat(8)-0.01%
EPS beat(12)4
Avg EPS beat(12)-0.74%
EPS beat(16)6
Avg EPS beat(16)-0.44%
Revenue beat(2)0
Avg Revenue beat(2)-1.49%
Min Revenue beat(2)-2.1%
Max Revenue beat(2)-0.87%
Revenue beat(4)0
Avg Revenue beat(4)-5.21%
Min Revenue beat(4)-13.79%
Max Revenue beat(4)-0.87%
Revenue beat(8)0
Avg Revenue beat(8)-3.29%
Revenue beat(12)1
Avg Revenue beat(12)-2.9%
Revenue beat(16)2
Avg Revenue beat(16)-2.48%
PT rev (1m)6.47%
PT rev (3m)5.27%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.27%
EPS NY rev (1m)0%
EPS NY rev (3m)0.8%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.39%
Revenue NY rev (1m)1%
Revenue NY rev (3m)1.15%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.13 | ||
| Fwd PE | 27.2 | ||
| P/S | 8.21 | ||
| P/FCF | 73.01 | ||
| P/OCF | 51.92 | ||
| P/B | 4.49 | ||
| P/tB | 6.34 | ||
| EV/EBITDA | 24.55 |
EPS(TTM)2.21
EY3.32%
EPS(NY)2.45
Fwd EY3.68%
FCF(TTM)0.91
FCFY1.37%
OCF(TTM)1.28
OCFY1.93%
SpS8.11
BVpS14.82
TBVpS10.5
PEG (NY)N/A
PEG (5Y)4.23
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 32.1% | ||
| ROE | 41.28% | ||
| ROCE | 13.2% | ||
| ROIC | 9.29% | ||
| ROICexc | 13.98% | ||
| ROICexgc | 22.62% | ||
| OM | 27.71% | ||
| PM (TTM) | 75.48% | ||
| GM | 79.38% | ||
| FCFM | 11.25% |
ROA(3y)21.77%
ROA(5y)18.87%
ROE(3y)29.68%
ROE(5y)26.56%
ROIC(3y)12.44%
ROIC(5y)13.58%
ROICexc(3y)16.13%
ROICexc(5y)17.4%
ROICexgc(3y)22.87%
ROICexgc(5y)24.4%
ROCE(3y)17.66%
ROCE(5y)19.29%
ROICexcg growth 3Y-5.47%
ROICexcg growth 5Y-8.01%
ROICexc growth 3Y-11.82%
ROICexc growth 5Y-8.6%
OM growth 3Y-5.94%
OM growth 5Y-1.04%
PM growth 3Y38.76%
PM growth 5Y26.09%
GM growth 3Y1.43%
GM growth 5Y1.33%
F-Score7
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.06 | ||
| Debt/FCF | 0.96 | ||
| Debt/EBITDA | 0.35 | ||
| Cap/Depr | 165.1% | ||
| Cap/Sales | 4.57% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 51.91% | ||
| Profit Quality | 14.9% | ||
| Current Ratio | 4.45 | ||
| Quick Ratio | 3.66 | ||
| Altman-Z | 12.15 |
F-Score7
WACC8.81%
ROIC/WACC1.05
Cap/Depr(3y)185.14%
Cap/Depr(5y)236.01%
Cap/Sales(3y)5.48%
Cap/Sales(5y)6.41%
Profit Quality(3y)37.92%
Profit Quality(5y)57.13%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.77%
EPS 3Y5.52%
EPS 5Y7.13%
EPS Q2Q%-4.29%
EPS Next Y-2.43%
EPS Next 2Y4.32%
EPS Next 3Y6.72%
EPS Next 5Y9.07%
Revenue 1Y (TTM)-1.09%
Revenue growth 3Y1.3%
Revenue growth 5Y4.58%
Sales Q2Q%-6.13%
Revenue Next Year3.42%
Revenue Next 2Y6.49%
Revenue Next 3Y7.7%
Revenue Next 5Y8.27%
EBIT growth 1Y-8.81%
EBIT growth 3Y-4.72%
EBIT growth 5Y3.49%
EBIT Next Year10.05%
EBIT Next 3Y11.53%
EBIT Next 5Y11.13%
FCF growth 1Y-36.77%
FCF growth 3Y-42.99%
FCF growth 5Y-22.01%
OCF growth 1Y-29.28%
OCF growth 3Y-32.1%
OCF growth 5Y-14.39%